Shandong Intco Medical Products Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Shandong Intco Medical Products Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shandong Intco Medical Products Co Ltd (300677) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥451.59 Million ≈ $66.08 Million USD) by net assets (CN¥18.47 Billion ≈ $2.70 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shandong Intco Medical Products Co Ltd (2013–2025)

Cash flow conversion efficiency of Shandong Intco Medical Products Co Ltd from 2013 to 2025. This chart illustrates how Shandong Intco Medical Products Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Intco Medical Products Co Ltd (300677) stock price for real-time trading data and today's change.

Shandong Intco Medical Products Co Ltd Cash Flow Conversion Ratio Explained

Shandong Intco Medical Products Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shandong Intco Medical Products Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Intco Medical Products Co Ltd ranked by their cash flow conversion efficiency. Also see 300677 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mobile World Investment Corp VN:MWG	0.467x
Solaris Energy Infrastructure, Inc. NYSE:SEI	0.072x
Cencosud Shopping SA SN:CENCOMALLS	0.020x
Belden Inc NYSE:BDC	0.093x
Nordstrom Inc NYSE:JWN	0.786x
Metsera, Inc. Common Stock NASDAQ:MTSR	-0.131x
Sk Biopharmaceuticals Co Ltd KO:326030	0.019x
Tidewater Inc NYSE:TDW	0.062x

Annual Cash Flow Conversion Efficiency for Shandong Intco Medical Products Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Intco Medical Products Co Ltd from 2013 to 2025. Review Shandong Intco Medical Products Co Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥18.57 Billion ≈ $2.72 Billion	CN¥1.89 Billion ≈ $275.84 Million	0.101x	+66.32%
2024-12-31	CN¥17.68 Billion ≈ $2.59 Billion	CN¥1.08 Billion ≈ $157.90 Million	0.061x	+97.93%
2023-12-31	CN¥16.29 Billion ≈ $2.38 Billion	CN¥502.41 Million ≈ $73.52 Million	0.031x	-53.56%
2022-12-31	CN¥16.05 Billion ≈ $2.35 Billion	CN¥1.07 Billion ≈ $155.91 Million	0.066x	-87.67%
2021-12-31	CN¥16.12 Billion ≈ $2.36 Billion	CN¥8.68 Billion ≈ $1.27 Billion	0.538x	-40.82%
2020-12-31	CN¥9.44 Billion ≈ $1.38 Billion	CN¥8.59 Billion ≈ $1.26 Billion	0.910x	+314.40%
2019-12-31	CN¥1.50 Billion ≈ $219.76 Million	CN¥329.69 Million ≈ $48.24 Million	0.220x	+50.44%
2018-12-31	CN¥1.27 Billion ≈ $186.29 Million	CN¥185.78 Million ≈ $27.19 Million	0.146x	-35.88%
2017-12-31	CN¥1.09 Billion ≈ $159.14 Million	CN¥247.48 Million ≈ $36.21 Million	0.228x	+51.14%
2016-12-31	CN¥535.45 Million ≈ $78.35 Million	CN¥80.62 Million ≈ $11.80 Million	0.151x	-18.06%
2015-12-31	CN¥415.19 Million ≈ $60.76 Million	CN¥76.29 Million ≈ $11.16 Million	0.184x	-59.96%
2014-12-31	CN¥168.38 Million ≈ $24.64 Million	CN¥77.28 Million ≈ $11.31 Million	0.459x	-8.96%
2013-12-31	CN¥147.82 Million ≈ $21.63 Million	CN¥74.52 Million ≈ $10.91 Million	0.504x	--

About Shandong Intco Medical Products Co Ltd

SHE:300677 China Medical Instruments & Supplies

Market Cap

$4.13 Billion

CN¥28.21 Billion CNY

Market Cap Rank

#3912 Global

#503 in China

Share Price

CN¥43.08

Change (1 day)

-2.75%

52-Week Range

CN¥37.39 - CN¥65.66

All Time High

CN¥151.71